The global lip injection market is expected to reach US$7.8 billion by 2034, up from US$3.8 billion in 2024. The market is projected to expand at a compound annual growth rate (CAGR) of 7.4 per cent between 2025 and 2034. Growing demand for minimally invasive cosmetic procedures continues to fuel market growth. Consumers increasingly prefer treatments that deliver quick results ...
Hugel Inc. has officially launched its botulinum toxin brand Letybo in India, marking another milestone in its global expansion strategy. The company announced its market entry during the Global Aesthetics Summit (GAS), held in Goa from 19 to 21 July. India is emerging as a key growth market for medical aesthetics. Rising disposable incomes, a growing middle class and increasing ...
Skin smoothing injectable fillers continue to show strong global growth as demand rises for minimally invasive aesthetic treatments. The market expands steadily as consumers prefer non-surgical options for facial rejuvenation. Industry reports confirm increasing adoption across dermatology clinics, med spas, and cosmetic centres. The global market is valued at around USD 252.72 million in 2025. It is projected to reach ...
The Asia Pacific (APAC) non-invasive aesthetic treatment market is experiencing strong expansion driven by rising disposable incomes and evolving beauty standards. Consumers increasingly prefer minimally invasive procedures due to convenience and lower recovery time. According to Precedence Market research indicates steady long-term growth across the region. The sector is expected to expand significantly over the next decade. The market was ...
Botulinum toxin and dermal fillers remain two of the highest-demand minimally invasive aesthetic procedures in India. However, practitioners continue to report significant patient confusion between the two modalities. According to Dr Akanksha Agarwal, Founder-Director and Head of Aesthetic Services at the Centre for Aesthetics, Gurgaon, Botox and fillers address entirely different anatomical concerns. They should not be positioned as interchangeable ...